	US 12,343,414 B2
	Oral care compositions and methods of use
Lisa Marie Manus, Lawrenceville, NJ (US); Jonghun Lee, Metuchen, NJ (US); Joseph Allan McKinnon Steele, Plainfield, NJ (US); Shaopeng Xu, Guangzhou (CN); and Yuzhi Deng, Guangzhou (CN)
Assigned to Colgate-Palmolive Company, New York, NY (US)
Appl. No. 17/765,382
Filed by Colgate-Palmolive Company, New York, NY (US)
PCT Filed Mar. 3, 2022, PCT No. PCT/CN2022/078926 § 371(c)(1), (2) Date Mar. 30, 2022, PCT Pub. No. WO2022/184115, PCT Pub. Date Sep. 9, 2022.
Claims priority of application No. 202110248821.7 (CN), filed on Mar. 5, 2021.
Prior Publication US 2023/0190595 A1, Jun. 22, 2023
Int. Cl. A61K 8/27 (2006.01); A61K 8/21 (2006.01); A61K 8/44 (2006.01); A61K 8/73 (2006.01); A61P 31/04 (2006.01); A61Q 11/00 (2006.01)

CPC A61K 8/21 (2013.01) [A61K 8/27 (2013.01); A61K 8/442 (2013.01); A61K 8/735 (2013.01); A61P 31/04 (2018.01); A61Q 11/00 (2013.01)]

24 Claims

1. An oral care composition comprising:

a. zinc oxide and zinc citrate; and

b. hyaluronic acid (HA) or an alkali metal hyaluronate polymer with an average molecular weight ranging from about 300,000 Da to about 700,000 Da.